Haffkine Institute to roll out Covaxin in 8 months, targets 22.8 crore doses a year

Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra Government undertaking, is preparing for mass production of COVAXIN. In a recent conversation with ANI's Sandeep Rathod, MD HBPCL said, “We’ve received approval for Covaxin production & are in talks with Bharat Biotech for further process. We'll be initiating production in 8 months.” He further added, “We are aiming to produce 22.8 core doses annually. Center is providing us with financial aid of Rs 65 Crores. Maharashtra govt has also given us over Rs 93 Crores.”